Y Chen, D Samineni, S Mukadam, H Wong… - Clinical …, 2015 - hero.epa.gov
Abstract Background and Objectives Monomethyl auristatin E (MMAE, a cytotoxic agent), upon releasing from valine-citrulline-MMAE (vc-MMAE) antibody-drug conjugates (ADCs), is …
Y Chen, D Samineni, S Mukadam, H Wong… - Clinical …, 2015 - infona.pl
Background and Objectives Monomethyl auristatin E (MMAE, a cytotoxic agent), upon releasing from valine-citrulline-MMAE (vc-MMAE) antibody-drug conjugates (ADCs), is …
Y Chen, D Samineni, S Mukadam, H Wong… - Clinical …, 2015 - europepmc.org
Methods A PBPK model linking antibody-conjugated MMAE (acMMAE) to its catabolite unconjugated MMAE associated with vc-MMAE ADCs was developed using a mixed'bottom …
Y Chen, D Samineni, S Mukadam, H Wong… - Clinical …, 2014 - cir.nii.ac.jp
Physiologically Based Pharmacokinetic Modeling as a Tool to Predict Drug Interactions for Antibody-Drug Conjugates | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
Y Chen, D Samineni, S Mukadam… - Clinical …, 2015 - search.proquest.com
Abstract Background and Objectives Monomethyl auristatin E (MMAE, a cytotoxic agent), upon releasing from valine-citrulline-MMAE (vc-MMAE) antibody-drug conjugates (ADCs), is …
Y Chen, D Samineni, S Mukadam… - Clinical …, 2015 - pubmed.ncbi.nlm.nih.gov
Background and objectives Monomethyl auristatin E (MMAE, a cytotoxic agent), upon releasing from valine-citrulline-MMAE (vc-MMAE) antibody-drug conjugates (ADCs), is …
Y Chen, D Samineni, S Mukadam… - Clinical …, 2015 - search.ebscohost.com
Abstract Background and Objectives: Monomethyl auristatin E (MMAE, a cytotoxic agent), upon releasing from valine-citrulline-MMAE (vc-MMAE) antibody-drug conjugates (ADCs), is …
[引用][C]Physiologically Based Pharmacokinetic Modeling as a Tool to Predict Drug Interactions for Antibody-Drug Conjugates
Y Chen, D Samineni, S Mukadam, H Wong… - Clinical …, 2015 - Adis International